ECPC Cancer Summit: Making the Cancer Partnership work

Hosted by: ECPC

The event will start on: 13 Oct 10 09:30

And will end on: 14 Oct 10 16:45

At The SQUARE - Brussels Meeting Centre

rue Mont des Arts (Glass Entrance) , Brussels

Posted by: roman   

The ECPC Cancer Summit will be the platform in 2010 to call to all European stakeholders with a common aim and commitment to reducing cancer to support this flagship action of collaborative action against cancer.

The ECPC Cancer Summit will address the issue of reducing the burden of cancer, tackle inequalities across the EU, and disseminate information and knowledge about the work of the European Partnership on Action against Cancer.

The ECPC Cancer Summit t will bring together around 150 delegates, including cancer patient representatives, health policy makers, politicians and the professional oncology community and aims to create grass roots momentum for driving the Cancer Partnership forward, motivating different stakeholders to work together at European, national and regional level, ensuring that the actions are patient-centered and benefit citizens. It will communicate the work of the Cancer Partnership to a wide audience of stakeholders to citizens and patients at grass root level.

The ECPC Summit will address 6 key issues:

• Making the Cancer Partnership work
• Investing in Prevention & Screening
• Partnerships Crossing Borders - Striking a Balance between policy for excellence and a policy for cohesion
• Sharing Best Practice in Health Partnerships
• Importance of Cancer Research
• Cancer Information & Data: Investing in our Future

Please find here the preliminary agenda (as of 28 July) of the ECPC Cancer Summit.

Please see Press Release ECPC Cancer Summit

To register, please click on "Register for conference". ECPC Members can also apply for travel grants to the ECPC Summit!

The ECPC Cancer Summit arises from the project “ECPC Cancer Summit: Making the Cancer Partnership work” which has received funding from the European Union, in the framework of the Public Health Programme. The following additional sponsors are supporting the ECPC Cancer Summit with an unrestricted grant: Bristol-Myers Squibb, Novartis, Pfizer, Roche, Sanofi Pasteur MSD. The funding enables ECPC e.g. to provide travel grants to patient groups from across Europe to attend the Summit.